TCB Staff

Author’s archive

Breaking Out with Breakthrough Drugs?

Upsher-Smith’s move into developing innovative drugs gained momentum in July 2008 with its equity investment of $6 million in Proximagen Neuroscience, a London-based firm that already had a new Parkinson’s
Mix Master

Mix Master

After a career of formulating time- and money-saving pharmaceuticals at his Minnesota business, Upsher-Smith Laboratories, Ken Evenstad started blending one of the most prestigious pinot noirs in the country.